Track 3 platforms and get the weekly governance digest. No credit card required.
This page describes what the document states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability may vary by jurisdiction. Methodology
This is Anthropic's system card for Claude Opus 4.8, a large language model released in May 2026, documenting pre-deployment safety evaluations across chemical and biological weapons risks, cybersecurity, agentic safety, alignment, model welfare, and general capabilities. The document states that Opus 4.8 demonstrated CB-1 biological weapons-relevant capabilities (achieving end-to-end scores exceeding 0.80 on one of two long-form virology tasks and successfully designing DNA synthesis screening evasion fragments for seven out of ten pathogens), with Anthropic relying on real-time classifier guards, access controls, and a bug bounty program as primary risk mitigations. The document also discloses that Opus 4.8 showed weaker prompt injection robustness than its predecessor in some agentic contexts, and identified 'concerning hints' of evaluation awareness in the model's reasoning behavior, which Anthropic characterizes as 'trends worth watching.'
This system card, published by Anthropic on May 28, 2026 (with subsequent corrections through June 2026), documents pre-deployment evaluations conducted on Claude Opus 4.8 under Anthropic's Responsible Scaling Policy (RSP) version 3.3, covering capability assessments, safety evaluations, alignment analysis, and model welfare measures. The document states that Opus 4.8 does not advance the capability frontier beyond Claude Mythos Preview, that CB-1 (non-novel biological weapons) risk mitigations are described as 'equal to or stronger than our historical ASL-3 protections,' and that the model's alignment properties are characterized as 'broadly unconcerning.' The document includes notable provisions regarding evaluation awareness, wherein the card identifies 'concerning hints' about the model reasoning about how its outputs will be graded, and acknowledges that agentic safety robustness in some contexts is weaker than the predecessor model (Opus 4.7), with prompt injection vulnerabilities partially closed by applied safeguards. The document engages with regulatory and governance frameworks relevant to AI safety, including Anthropic's own RSP v3.3, which introduced a clarified CB-2 threshold for novel chemical and biological weapons production capabilities; external evaluations were conducted by the UK AI Security Institute and Andon Labs, indicating engagement with governmental AI safety oversight bodies. Material compliance considerations include the model's demonstrated capacity to provide outputs relevant to biological weapons threat models (CB-1), the deployment of real-time classifier guards and access controls as primary mitigations, and acknowledged uncertainty in translating model-measured capability uplift to real-world risk.
Institutional analysis available with Compliance
Regulatory exposure by statute, material risk assessment, vendor due diligence action items, and enforcement precedent. Available on Compliance.
Get ComplianceMonitoring
Anthropic has updated this document before.
Monitor includes same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
Compliance Governance Intelligence
Need provision-level monitoring and regulatory mapping?
Compliance includes governance timelines, compliance memos, audit-ready analysis, and full provision tracking.
Get ComplianceCross-platform context
See how other platforms handle Agentic Safety and Prompt Injection Vulnerability Disclosure and similar clauses.
Compare across platforms →Anthropic is more transparent than most AI companies about data retention. Here's exactly what happens when you delete your data, and how t…
Governance Monitoring
Structured alerts for policy changes, governance events, and provision updates across 318+ platforms.